Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stereotactic Multiple Fraction Radiotherapy for Non-spine Bone Metastases a Multicentre Prospective, Open Label, Randomised Controlled Phase 3 Non-inferiority Clinical Trial

NCT05406063 is registered in ClinicalTrials.gov with Kantonsspital Winterthur KSW as lead sponsor.

NCT NCT05406063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05406063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stereotactic Multiple Fraction Radiotherapy for Non-spine Bone Metastases a Multicentre Prospective, Open Label, Randomised Controlled Phase 3 Non-inferiority Clinical Trial
Lead sponsor
Kantonsspital Winterthur KSW
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2022
Completion date
May 31, 2026
Enrollment
162 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases, pain, radiation therapy